Department of Animal Biology, School of Veterinary Medicine, University of Pennsylvania, 3800 Spruce Street, Philadelphia, PA 19104, USA
* These authors contributed equally to this work
Author for correspondence (e-mail: saintj{at}vet.upenn.edu)
Accepted 24 October 2001
![]() |
SUMMARY |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Key words: Sox9, Neural crest, Craniofacial skeleton, Morpholino antisense, Xenopus
![]() |
INTRODUCTION |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
The molecular signals that control neural crest specification are not well understood. Signals emanating from the non-neural ectoderm, the paraxial mesoderm, or both, are believed to be involved in the specification of the neural crest (Selleck and Bronner-Fraser, 1995; Mancilla and Mayor, 1996; Bonstein et al., 1998; Marchant et al., 1998). There is evidence that molecules belonging to the bone morphogenetic protein (BMP) family, which are expressed by the non-neural ectoderm and the dorsal neural tube, initiate the formation of the neural crest (Liem et al., 1995; Liem et al., 1997). The neural inducers noggin and chordin act by neutralizing a BMP signal in the ectoderm (Zimmerman et al., 1996; Piccolo et al., 1996), thereby allowing neural crest to form in regions where BMPs and BMP antagonists reach an appropriate balance (Morgan and Sargent, 1997; Marchant et al., 1998; Nguyen et al., 1998). Fibroblast growth factor (FGF) signaling in conjunction with BMP inhibition can also induce neural crest fates (Mayor et al., 1997; LaBonne and Bronner Fraser, 1998). Recent studies in the mouse (Ikeya et al., 1997; Dunn et al., 2000), frog (Saint-Jeannet et al., 1997; Chang and Hemmati-Brivanlou, 1998; LaBonne and Bronner-Fraser, 1998; Bang et al., 1999; Deardorff et al., 2001) and zebrafish (Dorsky et al., 1998) have implicated the Wnt family of growth factors in neural crest formation. Ectopic expression of some Wnt family members enhances production of neural crest progenitors, and inhibition of Wnt signaling blocks neural crest formation. It is not clear whether Wnt signaling is required in the early phases of neural crest specification or later for the maintenance and/or proliferation of crest precursors.
In Xenopus, several transcription factors have been found to be expressed in the developing neural crest, including Slug (Mayor et al., 1995), Snail (Essex et al., 1993), Twist (Hopwood et al., 1989), Pax3 (Bang et al., 1997), Msx1 (Suzuki et al., 1997), Zic3 (Nakata et al., 1997), Zic5 (Nakata et al., 2000) and Foxd3 (Dirksen and Jamrich, 1995). While some of these have also been implicated at different levels in the regulation of neural crest formation or migration, or both (Nakata et al., 1997; Nakata et al., 2000; LaBonne and Bronner-Fraser, 2000; Pohl and Knochel, 2001; Sasai et al., 2001), the way in which these different factors interact in the context of the developing neural crest remains to be determined.
Sox proteins comprise a large class of transcription factors related to SRY, the testis-determining factor. They are characterized by the presence of an HMG-box, a sequence specific DNA-binding domain (Pevney and Lovell-Badge, 1997; Wegner, 1999). Expression of these proteins in defined cell types during embryogenesis appears to govern cell fate determination (Kamachi et al., 2000). One member of this family, mouse Sox9, has been shown to regulate cartilage formation by binding and activating the chondrocyte specific enhancer of collagen type II (Col2a1) (Bell et al., 1997; Bi et al., 1999). Consistent with this role, Col2a1 and Sox9 are co-expressed in all chondrogenic precursors (Zhao et al., 1997; Ng et al., 1997). Heterozygous mutations of Sox9 result in Campomelic Dysplasia (CD), a lethal human disorder characterized by autosomal XY sex reversal and severe skeletal malformations (Houston et al., 1983; Wagner et al., 1994), indicating a fundamental role for Sox9 in sex determination and skeletal development (Lefebvre and de Crombrugghe, 1997). During mouse embryogenesis, Sox9 is also expressed in neural crest progenitors (Zhao et al., 1997; Ng et al., 1997), but nothing is known about the early function of Sox9 in the developing neural crest. Interestingly, individuals with CD and Sox9 heterozygous mutant mice present defects in craniofacial skeletal elements of neural crest origin, the jaw and palate (Houston et al., 1983; Wagner et al., 1994; Bi et al., 2001), suggesting that Sox9 may play an important role in the development of a subset of neural crest derivatives.
We report the cloning and functional analysis of Xenopus Sox9 during neural crest development. Sox9 is expressed maternally and accumulates shortly after gastrulation at the lateral edges of the neural plate, in the neural crest-forming region. In this tissue, Sox9 is spatially and temporally co-expressed with Slug, which is known to be the earliest gene activated in response to neural crest-inducing signals. Depletion of Sox9 in developing embryos, using morpholino antisense oligos (Heasman et al., 2000), causes a dramatic loss of early neural crest progenitors and a specific loss of cranial skeletal elements, indicating a requirement for Sox9 function during development of cranial neural crest derivatives.
![]() |
MATERIALS AND METHODS |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
|
In vitro transcription/translation and western blot analysis
The in vitro transcription/translation coupled rabbit reticulocyte lysate system (SP6-TNT, Promega) was used according to the manufacturer recommendations (Promega) in the presence of [35S]methionine and resolved on a NuPAGE BIS-Tris gel (Invitrogen). For western blot analysis the in vitro transcription/translation was performed in the presence of unlabeled methionine. The gel was blotted onto nitrocellulose, incubated in the presence of a Sox9 polyclonal antibody (Bridgewater et al., 1998) at a 1:1000 dilution, washed and incubated with anti-rabbit Ig coupled to horseradish peroxidase (Amersham Pharmacia Biotech, 1:5000 dilution). The product of the reaction was revealed using the SuperSignal West Femto Maximum Sensitivity Substrate from Pierce and detected by exposure onto a BioMax film (Kodak). The specificity of the morpholino antisense oligo was determined by adding 1 µg of Co-AS or Sox9-AS to the vitro transcription/translation reaction. To analyze the activity of the morpholino antisense oligo in vivo, embryos were injected at the two-cell stage with 1 ng of Sox9 mRNA (Sox9+5'utr) in the presence of 10 ng of Sox9-AS or Co-AS. Embryos were then collected at stage 17, homogenized, resolved on a NuPAGE BIS-Tris gel, blotted onto nitrocellulose and processed for western analysis as described above. Blots were stripped according to the manufacturer recommendations (Pierce) and probed with anti--tubulin antibody (Sigma, 1:500 dilution).
Immunofluorescence
Embryos at the two-cell stage were injected in the animal pole with 1 ng of Sox9 mRNA and animal explants dissected at the blastula stage. At equivalent stage 12, animal explants were fixed in methanol at 80°C, embedded in Paraplast+, sectioned and processed for immunostaining. Briefly, sections were blocked in PBS plus 5% fetal calf serum and incubated successively in the presence of Sox9 polyclonal antibody (1:30 dilution), anti-rabbit Ig coupled to FITC (Jackson, 1:100 dilution) and DAPI (5 mg/ml). Sections were mounted in glycerol and observed under an epifluorescence microscope.
Northern hybridization
RNA extraction, electrophoresis, blotting and hybridization was performed as described (Taira et al., 1992; Spokony and Saint-Jeannet, 2000).
Lineage tracing and in situ hybridization
Embryos were co-injected with ß-galactosidase mRNA (ß-gal, 1 ng). By stage 17 embryos were fixed in MEMFA (Harland, 1991) and successively processed for X-Gal (Promega) or Red-Gal (Research Organics) staining and in situ hybridization. Antisense FITC- or DIG-labeled probes (Genius kit, Roche) were synthesized using template cDNA encoding Nrp1 (Knecht et al., 1995), Sox2 (Mizuseki et al., 1998a), Slug (Mayor et al., 1995), Snail (Essex et al., 1993), Pax3 (Bang et al., 1997), Foxd3 (XFKH6) (Dirksen and Jamrich, 1995), Twist (Hopwood et al., 1989), xFKBP (Spokony and Saint-Jeannet, 2000), Trp2 (E. M.-F. and J.-P. S.-J. unpublished), Msx1 and Dlx3 (Feledy et al., 1999). Whole-mount in situ hybridization was performed as previously described (Harland, 1991). Sox9 in situ hybridization was performed using pGEMTSox9 construct as template. For histology, stained embryos were embedded into Paraplast+, 12 µm sections cut on a rotary microtome and briefly counterstained with Eosin.
Cartilage staining
Alcian Blue staining of stage 45 embryos was performed essentially as described (Berry et al., 1998). Briefly, embryos were fixed overnight in 10% formaldehyde, rinsed in tap water, skinned and eviscerated. Embryos were then dehydrated and stained in Alcian blue for 12 hours. After several rinses in 95% ethanol, embryos were rehydrated and macerated in 2% potassium hydroxide. Specimens were then transferred successively in 20%, 40%, 60% and 80% glycerol in 2% potassium hydroxide. The ethmoidal plate was dissected out and specimens mounted flat under a coverslip in 80% glycerol.
![]() |
RESULTS |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
|
Sox9 is expressed in the developing neural crest
To determine the spatial expression pattern of Sox9, we performed whole-mount in situ hybridization on a variety of embryonic stages. The first localized expression of Sox9 can be observed at stage 10.5-11, when transcripts are found in a superficial ring around the blastopore with signal decreasing towards the dorsal side (Fig. 2A). At stage 12 the staining decreases around the blastopore and accumulates at the lateral edges of the neural plate (Fig. 2B), the position of the prospective neural crest. This dynamic expression pattern around the blastopore and in the neural crest-forming region is reminiscent of the expression of another transcription factor, maker of the neural crest in Xenopus, Snail (Essex et al., 1993; Linker et al., 2000).
|
Early on, Sox9 expression in the neural crest-forming regions is spatially and temporally identical to that of Slug and Snail, known to be the earliest genes activated in response to neural crest-inducing signals in Xenopus. Furthermore, Sox9 expression is maintained as neural crest cells migrate in the cranial region and invade the pharyngeal arches. These observations suggest that Sox9 may play an important role in the formation and development of cranial neural crest cells.
Sox9-AS-injected embryos lack neural folds
To investigate Sox9 function during early neural crest development, we performed loss-of-function studies using morpholino antisense oligonucleotides (Summerton and Weller, 1997; Heasman et al., 2000). A Sox9 morpholino antisense oligo (Sox9-AS) was designed against the 5'UTR of Xenopus Sox9, directly upstream of the translation start site. Embryos at the two-cell stage were injected in one blastomere with 10 ng of Sox9-AS or control oligo (Co-AS, composed of a random sequence) together with mRNA encoding the lineage tracer ß-galactosidase. At the early neurula stage, Co-AS-injected embryos appeared to develop normally (Fig. 3D-F), while Sox9-AS-injected embryos failed to form a distinct neural fold on the injected side (Fig. 3A-C). Transverse sections through Sox9-AS-injected embryos confirmed the absence of a well-defined neural fold (Fig. 3B,C) when compared with Co-AS-injected embryos (Fig. 3E,F). Importantly, surrounding tissues (somites and notochord) appeared unaffected in Sox9-AS-injected embryos (Fig. 3C). The neural crest-forming region (neural fold) appears to be primarily affected in these embryos (Fig. 3G), consistent with Sox9 expression in this tissue.
Sox9-AS specifically blocks translation of Sox9 mRNA
To verify the specificity of Sox9-AS, we generated two constructs that encompass the entire open reading frame of Sox9 (Sox9) with one of the constructs also containing 50 nucleotides of 5'UTR (Sox9+5'UTR). The 50 bp of 5'UTR includes the 28 bp target sequence for Sox9-AS. Using a Sox9-specific antibody (Fig. 1A) (Bridgewater et al., 1998), we performed western blot analysis of in vitro transcription/translation products directed by each of the Sox9 cDNAs or by another Sox family member, Xenopus Sox2. The anti-Sox9 antibody recognizes only the major product of Sox9 reactions (Fig. 4A). Addition of Sox9-AS oligo to the reaction caused a dramatic reduction in the amount of Sox9 protein produced by Sox9+5'UTR construct, but failed to alter the level of Sox9 protein generated from the Sox9 construct that lacked the 5'UTR (Fig. 4B). Addition of a nonspecific control antisense oligo (Co-AS) had no effect on the translation of Sox9 mRNA derived from either construct (Fig. 4B). This result establishes that Sox9-AS specifically blocks the synthesis of Sox9 protein.
|
Sox9-AS prevents Slug expression in a dose-dependent manner
The transcription factor Slug (Mayor et al., 1995) is known to be the earliest gene activated in response to neural crest-inducing signals. Therefore, we analyzed the expression pattern of Slug in Sox9-AS-injected embryos. Upon injection of 10 ng of Sox9-AS into one blastomere at the two-cell stage, 94% of the embryos (n=158) showed a reduction (Fig. 5B) or a complete loss (Fig. 5C) of Slug expression on the injected side at stage 17. The percentage of affected embryos dropped to 61%, 35% and 18% for lower doses of Sox9-AS, 5 ng (n=112), 2 ng (n=130) and 1 ng (n=111) respectively (Fig. 5D), indicating that Sox9-AS blocks Slug expression in a dose-dependent manner. During normal development Slug is first detected in the neural crest forming region at the late gastrula stage (stage 12) (Mayor et al., 1995). Therefore, we asked whether Sox9-AS would prevent the early onset of Slug expression. Injection of 10 ng of Sox9-AS completely blocked Slug expression at stage 12 in 98% of the embryos analyzed (n=82, Fig. 5E). This result suggests that Sox9 function is required at the neural plate border at the initial stages of neural crest formation.
|
|
|
|
|
|
![]() |
DISCUSSION |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
At least nine Sox genes have been identified in Xenopus: Sox17- and -ß (Hudson et al., 1997); xSox12 (Komatsu et al., 1996); xSox7 (Shiozawa et al., 1996); XLS13A and 13B (Hiraoka et al., 1997); Sox2 (Misuzeki et al., 1998a); Sox3 (Penzel et al., 1997; Kayano et al., 1997; Sakai et al., 1997); and SoxD (Misuzeki et al., 1998b). Among these, Sox2, Sox3 and SoxD are expressed in overlapping domains in the dorsal ectoderm at the gastrula stage and remain confined to the early neural plate and developing neural tube throughout development (Misuzeki et al., 1998a; Penzel et al., 1997; Misuzeki et al., 1998b). While SoxD is believed to control induction of anterior neural tissue by attenuation of BMP4 signaling (Misuzeki et al., 1998b), Sox2 appears to act as a competence factor by conferring neural ectoderm responsiveness to FGF, a candidate posteriorizing signal (Kishi et al., 2000). Loss-of-function for SoxD and Sox2, by overexpression of truncated Sox proteins (which lack most of the DNA binding domain), resulted in a broad inhibition of neural as well as neural crest markers (Mizuseki et al., 1998b; Kishi et al., 2000; Sasai, 2001). Sox proteins are known to regulate their target genes through interaction with cell-specific partner factors (Kamachi et al., 2000). Therefore, we cannot exclude the possibility that these dominant negative proteins interfered broadly with the function of other Sox family members (including Sox9) by competing for similar partner molecules. By contrast, Sox9 loss-of-function, using morpholino antisense oligos, resulted in a strict loss of neural crest progenitors associated with an enlargement of the neural plate.
Current models for neural crest induction suggests that graded amounts of BMP signaling could be responsible for generating both neural and neural crest fates (LaBonne and Bronner-Fraser, 1999). The expansion of the neural plate tissue in Sox9-depleted embryos could reflect the inability of the embryo to regulate proper levels of BMP signaling in the neural folds. Thus, Sox9 activity would be required at the neural plate border to confer competence to respond to BMP signal. This type of activity would be reminiscent of the requirement for Sox2 in the neural ectoderm to confer responsiveness to FGF signaling (Kishi et al., 2000). Several Wnt molecules have been shown to regulate neural crest formation in Xenopus (Saint-Jeannet et al., 1997; Chang and Hemmati-Brivanlou, 1998; LaBonne and Bronner-Fraser, 1998; Bang et al., 1999; Deardorff et al., 2001). Therefore, Sox9 activity could also be required in the neural folds to regulate response to Wnt signaling, as previously proposed for other Sox family members during axis formation (Zorn et al., 1999).
What is the fate of Sox9-depleted cells that fail to contribute to the neural crest lineage? The expansion of the neural plate in Sox9-AS-injected embryos suggests that Sox9-depleted cells might be incorporated into the neuroepithelium. Consistent with this view, Sox9-depleted cells expressing the lineage tracer ß-gal were found among Sox2- and Nrp1-positive cells, suggesting that they may have adopted a neural plate fate (Fig. 6B). Additionally, ß-gal-positive cells were also detected in the non-neural ectoderm, indicating a possible epidermal fate. Nevertheless, we cannot exclude the possibility that some Sox9-depleted cells are eliminated by cell death. A more detailed analysis of this was prohibited by the high level of apoptosis normally occurring during early neurogenesis in Xenopus (data not shown) (Hensey and Gautier, 1998).
One of the well-characterized target genes of Sox9 during chondrocyte differentiation is the Col2a1 gene, which encodes type II collagen (Bell et al., 1997). Sox9 expression parallels that of Col2a1 during chondrogenesis (Ng et al., 1997; Zhao et al., 1997), and analysis of mouse chimeras using Sox9/ ES cells shows that Sox9/ cells are excluded from cartilage tissues and are unable to express Col2a1 (Bi et al., 1999). Because type II collagen is not expressed in Xenopus neural crest forming region (Su et al., 1991b), it is unlikely to be a target gene for Sox9 in this tissue. However, genes expressed in the neural crest-forming region, and downregulated in Sox9-depleted embryos, are likely to represent downstream targets of Sox9. These genes include Slug, Snail, Twist, Pax3, Msx1 and Foxd3. However, it is not clear at this time whether any of these genes are directly under the control of Sox9 or are positioned further downstream in the regulatory pathway that leads to neural crest formation.
Injection of Slug antisense mRNA in Xenopus resulted in an inhibition of neural crest migration, and caused a broad range of defects in cranial and trunk crest derivatives (Carl et al., 1999). Interestingly, in these embryos, early expression of Snail and Twist was not affected, consistent with a role of Slug in crest migration rather than specification (Carl et al., 1999). More recently, using a hormone-inducible inhibitory mutant of Slug (that interfere with Snail and Slug function), it has been proposed that Slug/Snail are in fact required for both neural crest formation and its subsequent migration (LaBonne and Bronner-Fraser, 2000). In Sox9-AS-injected embryos, Twist expression is completely eliminated. If neural crest cell migration rather than specification had been affected in Sox9-depleted embryos, one would expect to find accumulation of Twist-positive cells adjacent to the hindbrain at the tailbud stage, but this is not the case (Fig. 6A). This observation, together with the absence of expression of a variety of early neural crest markers, strongly indicates that Sox9 function is required for neural crest specification. However, because neural crest progenitors failed to form in Sox9-depleted embryos, it is difficult to rule out a later role for Sox9 in neural crest cell migration.
Sporadic autosomal dominant mutations in one Sox9 allele result in Campomelic Dysplasia (CD), a lethal human disorder characterized by XY sex reversal and severe skeletal malformations (Houston et al., 1983; Wagner et al., 1994). Individuals with CD also have defects in craniofacial skeletal elements of neural crest origin, the jaw and palate (Houston et al., 1983; Wagner et al., 1994). Similarly, Sox9 heterozygous mutant mice present major skeletal defects including a shortened jaw and cleft palate (Bi et al., 2001), consistent with early Sox9 expression in the neural crest-forming region (Zhao et al., 1997; Ng et al., 1997). Nevertheless, as Sox9 homozygous mutant embryos die midway through gestation (R. R. Behringer, personal communication), it is difficult to determine whether specific subsets of cranial crest derivatives are affected in these embryos. In Xenopus, Sox9 depletion leads to embryos with severe defects in a subset of cranial skeletal elements derived from the neural crest, including a complete loss of Meckels cartilage. Meckels cartilage originates from the first pharyngeal arch and makes a major contribution to the lower jaw. There is a striking similarity between the craniofacial phenotype observed in Xenopus Sox9-depleted embryos (missing jaws) and one aspect of the craniofacial defects described in individual with CD or Sox9 mutant mice (shortened jaws). Interestingly, neural crest-derived pigment cells form normally in the trunk region of Sox9-depleted embryos, suggesting that development of trunk crest derived pigment cells are not dependent on Sox9 activity. However, as pigment cell precursors continue to develop until fairly late during embryogenesis (LeDouarin and Kalcheim, 1999), we cannot exclude the possibility that by the time of their emergence, Sox9-AS may have lost its activity. Altogether, our results indicate a preferential requirement for Sox9 function in the development of some cranial neural crest derivatives.
During mouse embryogenesis, another Sox family member, Sox10, is expressed in the cells of the neural crest at the time of their emergence and is detected transiently in enteric neurons and melanoblasts. Sox10 persists in the peripheral nervous system into adulthood where it seems to be confined to the peripheral glia (Kuhlbrodt et al., 1998; Pusch et al., 1998; Britsch et al., 2001). Mutations in one Sox10 allele have been found in individuals that suffer from congenital aganglionic megacolon (Hirschsprung disease) associated with a combination of pigmentation defects and deafness (Waardenburg syndrome) (Pingault et al., 1998). In the spontaneous mouse mutant Dom, Sox10 carries a frameshift mutation. As a result, Dom mice suffer from a loss of neurons and glia cells in the peripheral nervous system, an absence of enteric neurons and pigmentation defects (Southard-Smith et al., 1998). Interestingly, humans and mice that carry mutations in Sox10 suffer from defects in trunk crest derivatives (enteric neurons, pigment cells and dorsal root ganglia), while cranial crest-derived structures (craniofacial cartilages and bones) appear largely unaffected, suggesting a preferential requirement for Sox10 function in the development of trunk neural crest derivatives.
Given the remarkable parallel between the activity of Sox9 in the cranial neural crest and Sox10 function in the trunk neural crest, we propose that during embryogenesis a limited number of Sox proteins, differentially expressed in the developing neural crest, are required for the specification and differentiation of subsets of neural crest derivatives as they emerge along the anteroposterior axis.
![]() |
ACKNOWLEDGMENTS |
---|
![]() |
REFERENCES |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Bang, A. G., Papalopulu, N., Kintner, C. and Goulding, M. D. (1997). Expression of Pax3 is initiated in the early neural plate by posteriorizing signals produced by the organizer and by posterior non-axial mesoderm. Development 124, 2075-2085.
Bang, A. G., Papalopulu, N., Goulding, M. D. and Kintner, C. (1999). Expression of Pax-3 in the lateral neural plate is dependent on a Wnt-mediated signal from the posterior nonaxial mesoderm. Dev. Biol. 212, 366-380.[Medline]
Bell, D. M., Leung, K. K. H., Wheatley, S. C., Ng, L. J., Zhou, S., Ling, K. W., Sham, M. H., Koopman, P., Tam, P. P. L. and Cheah, K. S. E. (1997). Sox9 directly regulates the type-II collagen gene. Nat. Genet. 16, 174-178.[Medline]
Bell, K. M., Western, P. S. and Sinclair, A. H. (2000). Sox8 expression during chick embryogenesis. Mech. Dev. 94, 257-260.[Medline]
Berry, D. L., Rose, C. S., Remo, B. F. and Brown, D. D. (1998). The expression pattern of thyroid hormone response genes in remodeling tadpole tissues defines distinct growth and resorbtion gene expression programs. Dev. Biol. 203, 24-35.[Medline]
Bi, W., Deng, J. M., Zhang, Z., Behringer, R. R. and de Crombrugghe, B. (1999). Sox9 is required for cartilage formation. Nat. Genet. 22, 85-89.[Medline]
Bi, W., Huang, W., Whitworth, D. J., Zhang, Z., Deng, J. M., Behringer, R. R. and de Crombrugghe, B. (2001). Haploinsufficiency of Sox9 results in defective precartilaginous mesenchymal condensations and premature skeletal mineralization. Proc. Natl. Acad. Sci. USA, 98, 6698-6703.
Bonstein, L., Elias, S. and Frank, D. (1998). Paraxial-fated mesoderm is required for neural crest induction in Xenopus embryos. Dev. Biol. 193, 156-168.[Medline]
Bridgewater, L. C., Lefebvre, V. and de Crombrugghe, B. (1998). Chondrocyte-specific enhancer elements in the Col11a2 gene resemble the Col2a1 tissue specific enhancer. J. Biol. Chem. 273, 14998-15006.
Britsch, S., Goerich, D. E., Riethmacher, D., Peirano, R. I., Rossner, M., Nave, K.-A., Birchmeier, C. and Wegner, M. (2001). The transcription factor Sox10 is a key regulator of peripheral gial development. Genes Dev. 15, 66-78.
Carl, T. F., Dufton, C., Hanken, J. and Klymkowsky, M. W. (1999). Inhibition of neural crest migration in Xenopus using antisense Slug RNA. Dev. Biol. 213, 101-115.[Medline]
Chang, C. and Hemmati-Brivanlou, A. (1998). Neural crest induction by Xwnt7B in Xenopus. Dev. Biol. 194, 129-134.[Medline]
Chiang, E.-L., Pai, C.-I., Wyatt, M., Yan, Y.-L., Postlethwait, J. and Chung, B.-C. (2001). Two Sox9 genes on duplicated zebrafish chromosomes: expression of similar transcription activators in distinct sites. Dev. Biol. 231, 149-163.[Medline]
Deardorff, M. A., Tan, C., Saint-Jeannet, J.-P. and Klein, P. S. (2001). A role for frizzled-3 in neural crest development. Development 128, 3655-3663.
Dirksen, M.-L. and Jamrich, M. (1995). Differential expression of the fork head genes during early Xenopus and Zebrafish development. Dev. Dyn. 17, 107-116.
Dorsky, R. I., Moon, R. T. and Raible, D. W. (1998). Control of neural crest cell fate by the Wnt signalling pathway. Nature 396, 370-373.[Medline]
Dunn, K. J., Williams, B. O., Li, Y. and Pavan, W. J. (2000). Neural crest-directed gene transfer demonstrates Wnt1 role in melanocyte expansion and differentiation during mouse development. Proc. Natl. Acad. Sci. USA 97, 10050-10055.
Essex, L. J., Mayor, R. M. and Sargent, M. G. (1993). Expression of snail in mesoderm and prospective neural fold ectoderm Dev. Dyn. 198 108-122.[Medline]
Feledy, J. A., Beanan, M. J., Sandoval, J. J., Goodrich, J. S., Lim, J. H., Matsuo-Takasaki, M., Sato, M. S. and Sargent T. D. (1999). Inhibitory patterning of the anterior neural plate in Xenopus by homeodomain factors Dlx3 and Msx1. Dev. Biol. 212, 455-464.[Medline]
Graham, A. and Smith, A. (2001). Patterning the pharyngeal arches. BioEssays 23, 54-61.[Medline]
Harland, R. M. (1991). In situ hybridization: an improved whole-mount method for Xenopus embryos. Meth. Cell Biol. 36, 685-695.[Medline]
Healy, C., Uwanogho, D. and Sharpe, P. T. (1999). Regulation and role of Sox9 in cartilage formation. Dev. Dyn. 215, 69-78.[Medline]
Heasman, J., Kofron, M. and Wylie, C. (2000). ß-catenin signaling activity dissected in the early Xenopus embryo: a novel antisense approach. Dev. Biol. 222, 124-134.[Medline]
Hensey, C. and Gautier, J. (1998). Programmed cell death during Xenopus development: a spatio temporal analysis. Dev. Biol. 203, 36-48.[Medline]
Hiraoka, Y., Komatsu, N., Sakai, Y., Ogawa, M., Shiozawa, M. and Aiso, S. (1997). XLS13A and XLS13B: SRY-related genes of Xenopus laevis. Gene 197, 65-71.[Medline]
Hopwood, N. D., Pluck, A. and Gurdon, J. B. (1989). A Xenopus mRNA related to Drosophila twist is expressed in response to induction in the mesoderm and the neural crest. Cell 59, 893-903.[Medline]
Houston, C. S., Opitz, J. M., Spranger, J. W., Macpherson, R. I., Reed, M. H., Gilbert, E. F., Herrmann, J. and Schinzel, A. (1983). The campomelic Syndrome: Review, report of 17 cases, and follow-up on the currently 17-year-old boy first reported by Maroteaux et al., in 1971. Am. J. Med. Genet. 15, 3-28.[Medline]
Hudson, C., Clements, D., Friday, R. V., Stott, D. and Woodland, H. R. (1997). Xsox17 and -ß mediate endoderm formation in Xenopus. Cell 91, 397-405.[Medline]
Ikeya, M., Lee, S. M. K., Johnson, J. E., McMahon, A. P. and Takada, S. (1997). Wnt signaling is required for expansion of neural crest and CNS progenitors. Nature 389, 966-970.[Medline]
Kamachi, Y., Uchikawa, M. and Kondoh, H. (2000). Pairing Sox off with partners in the regulation of embryonic development.Trends Genet. 16, 182-187.[Medline]
Kayano, S., Ito, M., Takamatsu, N., Takiguchi, S. and Shiba, T. (1997). The Xenopus Sox3 gene expressed in oocytes of early stages. Gene 188, 101-107.[Medline]
Kishi, M., Mizuseki, K., Sasai, N., Yamazaki, H., Shiota, K., Nakanishi, S. and Sasai, Y. (2000). Requirement of Sox2-mediated signaling for differentiation of early Xenopus neuroectoderm. Development 127, 791-800.
Knecht, A. K., Good, P. J., Dawid, I. B. and Harland, R. M. (1995). Dorsoventral patterning and differentiation of noggin-induced neural tissue in the absence of mesoderm. Development 121, 1927-1936.
Komatsu, N., Hiraoka, Y., Shiozawa, M., Ogawa, M. and Aiso, S. (1996). Cloning and expression of Xenopus laevis xSox12 cDNA. Bioch. Biophys. Acta 1305, 117-119.[Medline]
Kuhlbrodt, K., Herbarth, B., Sock, E., Hermans-Borgmeyer, I. and Wegner, M. (1998). Sox10, a novel transcriptional modulator in glial cells J. Neurosc. 18, 237-250.
LaBonne, C. and Bronner-Fraser, M. (1998). Neural crest induction in Xenopus: evidence for a two-signals model. Development 125, 2403-2414.
LaBonne, C. and Bronner-Fraser, M. (1999). Molecular mechanisms of neural crest formation. Annu. Rev. Cell Dev. Biol. 15, 81-112.[Medline]
LaBonne, C. and Bronner-Fraser, M. (2000). Snail-related transcriptional repressors are required in Xenopus for both the induction of the neural crest and its subsequent migration. Dev. Biol. 221, 195-205.[Medline]
LeDouarin, N. M. and Kalcheim, C. (1999). The Neural Crest. 2nd edn. London: Cambridge University Press.
Lefebvre, V. and de Crombrugghe, B. (1997). Towards understanding Sox9 function in chondrocyte differentiation. Matrix Biol. 16, 529-540.
Liem, K. F., Tremml, G., Roelink, H. and Jessell, T. M. (1995). Dorsal differentiation of neural plate cells induced by BMP-mediated signals from epidermal ectoderm. Cell 82, 969-979.[Medline]
Liem, K. F., Tremml, G. and Jessell, T. (1997). A role for roof plate and its resident TGF-ß-related proteins in neuronal patterning in the dorsal spinal cord. Cell 91, 127-138.[Medline]
Linker, C., Bronner-Fraser, M. and Mayor, R. (2000). Relationship between gene expression domains of Xsnail, Xslug and Twist and cell movement in the prospective neural crest of Xenopus. Dev. Biol. 224, 215-225.[Medline]
Mancilla, A. and Mayor, R. (1996). Neural crest formation in Xenopus laevis: mechanism of Xslug induction. Dev. Biol. 177, 580-589.[Medline]
Marchant, L., Linker, C., Ruiz, P., Guerrero, N. and Mayor, R. (1998). The inductive properties of mesoderm suggest that the neural crest cells are specified by a BMP gradient. Dev. Biol. 198, 319-329.[Medline]
Mayor, R., Morgan, R. and Sargent, M. (1995). Induction of the prospective neural crest of Xenopus. Development 121, 767-777.
Mayor, R., Guerrero, N. and Martinez, C. (1997). Role of FGF and noggin in neural crest induction. Dev. Biol. 189, 1-12.[Medline]
Mizuseki, K., Kishi, M., Matsui, M., Nakanishi, S. and Sasai, Y. (1998a). Xenopus Zic-related-1 and Sox-2, two factors induced by chordin, have distinct activities in the initiation of neural induction. Development 125, 579-587.
Mizuseki, K., Kishi, M., Shiota, K., Nakanishi, S. and Sasai, Y. (1998b). SoxD: an essential mediator of induction of anterior neural tissues in Xenopus embryos. Neuron 21, 77-85.[Medline]
Morgan, R. and Sargent, M. G. (1997). The role in neural patterning of translation initiation factor eIF4AII; induction of neural fold genes. Development 124, 2751-2760.
Nakata, K., Nagai, T., Aruga, J. and Mikoshiba, K. (1997). Xenopus Zic3, a primary regulator both in neural and neural crest development. Proc. Natl. Acad. Sci. USA 94, 11980-11985.
Nakata, K., Koyabu, Y., Aruga, J. and Mikoshiba, K. (2000). A novel member of the Xenopus Zic family, Zic5, mediates neural crest development. Mech. Dev. 99, 83-91.[Medline]
Ng, L. J., Wheatley, S., Muscat, G. E. O., Conway-Campbell, J., Bowles, J., Wright, E., Bell, D. M., Tam, P. P. L., Cheah, K. S. E. and Koopman, P. (1997). SOX9 binds DNA, Activates transcription, and coexpresses with type II collagen during chondrogenesis in the mouse. Dev. Biol. 183, 108-121.[Medline]
Nguyen, V. H., Schmid, B., Trout, J., Connors, S. A., Ekker, M. and Mullins, M. C. (1998). Ventral and lateral regions of the zebrafish gastrula, including the neural crest progenitors, are established by a bmp2b/swirl pathway of genes. Dev. Biol. 199, 93-110.[Medline]
Nieuwkoop, P. D. and Faber, J. (1967). Normal table of Xenopus laevis (Daudin). Amsterdam: North Holland Publishing Company.
Penzel, R., Oschwald, R., Chen, Y., Tacke, L. and Grunz, H. (1997). Characterization and early embryonic expression of a neural specific transcription factor xSOX3 in Xenopus laevis. Int. J. Dev. Biol. 41, 667-677.[Medline]
Pevney, L. H. and Lovell-Badge, R. (1997). Sox genes find their feet. Curr. Opin. Genet. Dev. 7, 338-344.[Medline]
Piccolo, S., Sasai, Y., Lu, B. and de Robertis, E. M. (1996). Dorsoventral patterning in Xenopus: inhibition of ventral signals by direct binding of chordin to BMP-4. Cell 86, 589-598.[Medline]
Pingault, V., Bondurand, N., Kuhlbordt, K., Goerich, D. E., Prehu, M-O., Puliti, A., Herbarth, B., Hermans-Borgmeyer, I., Leguis E., Matthijs, G. et al. (1998). SOX10 mutations in patients with Waardenburg-Hirschprug disease. Nat. Genet. 18, 171-173.[Medline]
Pohl, B. S. and Knochel, W. (2001). Overexpression of the transcriptional repressor FoxD3 prevents neural crest formation in Xenopus embryos. Mech. Dev. 103, 93-106.[Medline]
Pusch, C., Hustert E., Pfeifer, D., Sudbeck, P., Kist, R., Roe, B., Wang, Z., Balling, R., Blin, N. and Scherer, G. (1998). The SOX10/Sox10 gene from human and mouse: sequence, expression, and transactivation by the encoded HMG domain transcription factor. Hum. Genet. 103, 115-123.[Medline]
Sadaghiani, B. and Thiebaud, C. H. (1987). Neural crest development in the Xenopus laevis embryo, studied by interspecific transplantation and scanning electron microscopy. Dev. Biol. 124, 91-110.[Medline]
Saint-Jeannet, J.-P., He, X., Varmus, H. E. and Dawid, I. B. (1997). Regulation of dorsal fate in the neuraxis by Wnt-1 and Wnt-3a. Proc. Natl. Acad. Sci. USA 94, 13713-13718.
Sakai, Y., Hiraoka, Y., Konishi, M., Ogawa, M. and Aiso, S. (1997). Isolation and characterization of Xenopus laevis xSOX-B1 cDNA. Arch. Biochem. Biophys. 346, 1-6.[Medline]
Sasai, Y. (2001). Role of Sox factors in neural determination: conserved signaling in evolution? Int. J. Dev. Biol. 45, 321-326.[Medline]
Sasai, N., Mizuseki, K. and Sasai, Y. (2001). Requirement of FoxD3-class signaling for neural crest determination in Xenopus. Development 128, 2525-2536.
Selleck, M. A. and Bronner-Fraser, M. (1995). Origins of the avian neural crest: The role of neural plate-epidermal interactions. Development 121, 525-538.
Shiozawa, M., Hiraoka, Y., Komatsu N., Ogawa, M., Sakai, Y. and Aiso, S. (1996). Cloning and characterization of the Xenopus laevis xSox7 cDNA. Biochim. Biophys. Acta 1309, 73-76.[Medline]
Southard-Smith, E. M., Kos, L. and Pavan, W. J. (1998). Sox10 mutation disrupts neural crest development in Dom Hirschprung mouse model. Nat. Genet. 18, 60-64.[Medline]
Spokony R. F. and Saint-Jeannet J.-P. (2000). Xenopus FK 506-binding protein, a novel immunophilin expressed during early development. Mech. Dev. 94, 205-208.[Medline]
Su, M., Suzuki, H. R., Solursh, M. and Ramirez, F. (1991a). Progressively restricted expression of a new homeobox-containing gene during Xenopus laevis embryogenesis. Development 111, 1179-1187.[Abstract]
Su, M-W, Suzuki, H. R., Bieker, J. J., Solursh, M. and Ramirez, F. (1991b). Expression of two nonallelic type II Procollagen genes during Xenopus leavis embryogenesis is characterized by stage specific production of alternatively spliced transcripts. J. Cell Biol. 115, 565-575.[Abstract]
Summerton, J. and Weller, D. (1997). Morpholino antisense oligomers: Design, preparation and properties. Antisense Nucleic Acid Drug Dev. 7, 187-195.
Suzuki, A., Ueno, N. and Hemmati-Brivanlou, A. (1997). Xenopus msx1 mediates epidermal induction and neural inhibition by BMP4. Development 124, 3037-3044.
Taira, M., Jamrich, M., Good, P. and Dawid, I. B. (1992). The LIM domain-containg homeo box gene Xlim-1 is expressed specifically in the organizer region of Xenopus gastrula embryos. Genes Dev. 6, 356-366.[Abstract]
Turner, D. L. and Weintraub, H. (1994). Expression of achaete-scute homolog 3 in Xenopus embryos convert ectodermal cells to neural fate. Genes Dev. 8, 1434-1447.[Abstract]
Wagner, T., Wirth, J., Meyer, J., Zabel, B., Held, M., Zimmer, J., Pasantes, J., Dagna Bricarelli, F., Keutel, J., Heustert, E. et al. (1994). Autosomal sex reversal and campomelic dysplasia are caused by mutations in and around the SRY-related gene SOX9. Cell 79, 1111-1120.[Medline]
Wegner, M. (1999). From head to toes: the multiple facets of Sox proteins. Nucleic Acid Res. 27, 1409-1420.
Western, P. S., Harry, J. L., Graves, J. A. M. and Sinclair, A. H. (1999). Temperature-dependent sex determination: upregulation of SOX9 expression after commitment to male development. Dev. Dyn. 214, 171-177.[Medline]
Wright, E., Hargrave, M. R., Christiansen, J., Cooper, L., Kun, J., Evans, T., Gangadharan, U., Greenfield, A. and Koopman, P. (1995). The Sry-related gene Sox9 is expressed during chondrocyte in mouse embryos. Nat. Genet. 9, 15-20.[Medline]
Zernicka-Goetz, M., Pines, J., Ryan, K., Siemering, K. R., Haseloff, J., Evans, M. J. and Gurdon, J. B. (1996). An indelible lineage marker for Xenopus using a mutated green fluorescent protein. Development 122, 3719-3724.
Zhao, Q., Eberspaecher, H., Lefebvre, V. and de Crombrugghe, B. (1997). Parallel expression of Sox9 and Col2a1 in cells undergoing chondrogenesis. Dev. Dyn. 209, 377-386.[Medline]
Zimmerman, L. B., de Jesus-Escobar, J. M. and Harland, R. (1996). The Spemann organizer signal noggin binds and inactivates bone morphogenetic protein 4. Cell 86, 599-606.[Medline]
Zorn, A. M., Barish, G. D., Williams, B. O., Lavender, P., Klymkowsky, M. W. and Varmus, H. E. (1999). Regulation of Wnt signaling by Sox proteins: XSox17/ß and XSox3 physically interact with ß-catenin. Mol. Cell 4, 487-498.[Medline]